Castle Connolly Medical Ltd. is a healthcare research and information company founded in 1991. Their goal is to help guide consumers to America’s top doctors and top hospitals using a detailed survey and comprehensive research

Dr Goldberg’s award recognizes him as one of the best doctors in the field of Ophthalmology. Dr Goldberg is credited as one of the first laser eye surgeons to help bring advanced technologies in the field to the United States. Dr. Daniel Goldberg has a rare dual certification from both the Council for Refractive Surgery Quality Assurance (an independent, nonprofit, patient and consumer health organization that evaluates and verifies the quality of the surgeries provided by select refractive surgeons in the United States), and the ABES( American Board of Eye Surgeons ). Nationwide, there are less than 10 LASIK surgeons with dual certification by ABES and CRSQA.

Dr Goldberg was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK. In 2000, at the ASCRS(American Society of Cataract and Refractive Surgeons) national meeting, the first large scale study of LASIK monovision was presented by Goldberg and the published paper appeared in 2001 in the Journal of Cataract and Refractive Surgery. Further research by Goldberg resulted in another large study of LASIK monovision which was published in 2003—this work compared results in far-sighted eyes as well as near-sighted eyes. Based on this research, Goldberg made presentations at national meetings on “Succeeding with LASIK Monovision” and taught courses at the ASCRS meetings on “Surgical correction of Presbyopia.”

In April of 2008, Dr Goldberg was recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

For more information, visit www.goldberg4lasik.com

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  He was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.  

Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures.  He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) – a new technology to correct nearsightedness in individuals with extremely high prescriptions. 

In 2008, Dr Goldberg was also recently honored by Castle Connolly Medical who presented him with their annual ‘Top Doctor” award which recognizes him as one of the best doctors in the field of Ophthalmology.  Then, in April of 2008, Dr Goldberg was again recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

Dr Goldberg is constantly on the forefront of groundbreaking technology and innovations in the field of Ophthalmology.  Currently Dr Goldberg is leading a worldwide study testing the effectiveness of using 5% Betadine irrigation for the treatment of acute EKC- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.  Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study and can do so by visiting http://www.betadineforekc.com/submission-process.aspx.   

More information on Dr Daniel Goldberg is available at http://www.goldberg4lasik.com/

The purpose of the new study is to confirm the effectiveness of this protocol and to expand the awareness amongst eye care professionals of this inexpensive treatment for EKC. 

 The treatment of EKC using betadine has been widely debated for years, but new research is shedding positive light on the treatment.  The Ocular Surgery News website, www.osnsupersite.com, recently interviewed Dr Goldberg about his new study and about using betadine as a treatmentn for EKC.

To read the full interview and article on the Ocular Surgery News website, visit http://www.osnsupersite.com/view.aspx?rid=41471

Participation in the study is open to ophthalmologists, US and international, who agree to follow the protocol and report clinical results thru the Betadine for EKC website (http://www.betadineforekc.com/Default.aspx ). The initial phase will be collecting data thru October 1, 2009, and it is anticipated that subsequently there will be modifications to the protocol and study design.

For more information about the new study, please visit http://www.betadineforekc.com/the-study.aspx

Information on registration is available at http://www.betadineforekc.com/submission-process.aspx

The evolution of comprehensive refractive surgery is opening new doors to those who were once told that better vision through LASIK surgery was not an option for them.  A comprehensive refractive surgeon can perform all aspects of vision correction including cornea remodeling and cataract surgery.  These procedures may help provide relief and enhanced vision under circumstances when LASIK cannot.

A Comprehensive Refractive Surgeon has skilled expertise in advanced Cataract and Corneal surgery and can offer alternative solutions for vision correction when LASIK has been ruled out.  Vision correction through refractive surgery can be achieved through:

• Laser Vision Correction
• Refractive Cataract Surgery
• Implantable Contact Lens (Visian ICL)
• Multifocal and Accommodating IOLs (ReStor and Crystalens)
• Monovision with IOLs or Laser Vision Correction
• Advanced Astigmatism Options (Toric IOLs and Corneal Relaxing Incisions)
• INTACS for Keratoconus

Consumers considering vision correction through surgery should consult with a comprehensive refractive surgeon who is skilled in the broad spectrum of refractive surgery.  There are many options available for individuals with thin corneas, cataracts and severe astigmatism.  A comprehensive refractive surgeon can help decide which procedure is best.

New Jersey residents who are not candidates for LASIK vision correction are encouraged to visit the office of Dr. Daniel Goldberg, a Comprehensive Refractive Surgeon who is also is one of the top corneal and cataract surgeons in New Jersey. 

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  As a member of the elite team of doctors who performed clinical trials of LASIK in its early stages, Dr Goldberg was named by other eye physicians as one of the best doctors in America.  His initial research and findings led to the FDA approval of LASIK. Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures.  He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) – a new technology to correct nearsightedness in individuals with extremely high prescriptions.

Reason #1: Dr. Daniel Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon. Dr. Daniel Goldberg is one of less than 10 LASIK eye surgeons to hold a rare dual certification from both the Council for Refractive Surgery Quality Assurance (CRSQA) and the ABES (American Board of Eye Surgeons).

Reason #2: Practice Makes Perfect

When it comes to perfection, no one scores higher then Dr. Goldberg. With over 30 years of experience and more than 10,000 LASIK eye surgery procedures performed, Dr. Goldberg is setting the standard for expertise in LASIK eye surgery in the US. He feels that surgical certification of actual surgical results and not just knowledge is vital to a patient’s safety and quality of results. Although it is not mandatory, Dr. Goldberg voluntarily validates the results of his surgeries through ABES and CRSQA as part of a service to his patients to demonstrate his expertise and commitment to safety in laser eye surgery.

Reason #3: The Most Advanced Technology

The Atlantic Laser Vision Center in Little Silver is committed to providing the best environment and the best technology for laser vision correction. The center continues to upgrade its lasers to provide the latest technologies and the best results. The Atlantic Laser Vision Center is the first in New Jersey, and one of the first in the US, to combine the Intralase femtosecond all-laser, no-blade flap with the VISX customized excimer laser platform. The center also uses the WaveScan Wavefront analyzer. The WaveScan is estimated to be 25X more accurate than measurements with lenses used in eyeglasses and contact lenses. All of these technology advances result in safer, more accurate laser vision correction results for patients at the Atlantic Laser Center in Little Silver.

Reason #4: You’re In Good Company

The staff at the Atlantic Laser Vision Center is there for one reason only; YOU! Our professional and caring staff members are here to assist you in any way possible. You won’t find abrupt or discourteous staff members here. Our staff’s time is dedicated to ensuring you receive the best treatment and have the most enjoyable experience possible. Our time is devoted to you.

Reason #5: The Facility

Your comfort and satisfaction is our top priority. You can be sure that you are walking into a clean, comfortable and informative environment. To that end, we spare no expense in staff, equipment, or physical plant. We have two spacious waiting rooms for you and your family. Family members can watch the procedure exactly as the doctor sees it with powerful direct link technology equipped especially for them. It brings solace to those waiting for your procedure to be completed. This is just one of the many special touches we have added with your comfort in mind.

About Dr. Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon. Dr. Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery. Based in Monmouth County, New Jersey, Dr. Goldberg has performed LASIK on patients worldwide and was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages.

As we age, our ability to change focus for near vision diminishes because the crystalline lens inside the eye becomes less flexible.  If the eye is nearsighted it may still be possible to read without glasses as we get older, but if the eye is not nearsighted or if vision is corrected for distance with glasses, contact lenses or LASIK, then we generally begin to need reading glasses after 40 years of age.

Eyeglasses, bifocals or progressive lenses provide clear focus for both near and distance vision.   With contact lenses there are several options for reading including bifocal contact lenses or mono-vision fitting of contact lenses.  Mono-vision is a strategy to correct both distance and near vision without wearing glasses, and it can be achieved with contact lenses or with Laser Vision Correction such as LASIK . 

With mono-vision, the dominant eye is generally corrected for distance vision and the non-dominant eye is corrected for near vision creating 2 eyes with different focus.

Despite nearly 40 years of experience with contact lens mono-vision, Dr. Goldberg recalls that in the 1990’s “when refractive surgery evolved with excimer laser vision correction, such as LASIK, into a safe and accurate surgical alternative to glasses or contact lenses, there was great skepticism about mono-vision amongst both eye surgeons and patients.”  This is because mono-vision breaks our concept of binocular vision with both eyes having similar focusing power.  Patients wondered if mono-vision would cause headaches and dizziness, and eye surgeons doubted the success and viability of surgical mono-vision.

Daniel B Goldberg MD at the Atlantic Laser Vision Center in Little Silver New Jersey was one of the pioneers in New Jersey laser vision correction, and developed a successful practice in refractive eye surgery in the 1990’s.  As he recalls: “Most of the research in refractive surgery at that time related to the development of the laser technology. Prior to my clinical research on mono-vision there were very few reports on surgical mono-vision and no reports on LASIK mono-vision at all.” 

In Dr. Goldberg’s practice, the patients over 40 years of age were seeking answers about correcting their reading vision without glasses.  In his practice, up to 50% of the patients over 40 chose mono-vision and the level of success and satisfaction was even higher that patients with contact lens mono-vision.

In 2000, at the ASCRS(American Society of Cataract and Refractive Surgeons) national meeting, the first large scale study of LASIK mono-vision was presented by Goldberg and the published paper appeared in 2001 in the Journal of Cataract and Refractive Surgery.  Further research by Goldberg resulted in another large study of LASIK mono-vision which was published in 2003—this work compared results in far-sighted eyes as well as near-sighted eyes.  Based on this research, Goldberg made presentations at national meetings on “Succeeding with LASIK Mono-vision” and taught courses at the ASCRS meetings on “Surgical correction of Presbyopia.”

Since 2003, there have been several additional studies by other experts on LASIK mono-vision which have confirmed the success previously reported by Goldberg.  Several months ago, the FDA approved the use of the VISX CustomVueExcimer Laser for LASIK mono-vision.  The VISX CustomVueexcimer laser is part of the advanced iLASIK surgical platform distributed by American Medical Optics, and CustomVueMono-vision is part of the iLASIK program.  NASA and the US Navy and Air Force have recently chosen this technology for LASIK on their pilots.  The Atlantic Laser Vision Center in Little Silver New Jersey is one of several centers in New Jersey offering iLASIK.

In April, at the inaugural training sesseion for CustomVueMonovison in Chicago, Goldberg was honored to be recognized for helping to set the stage for the FDA approval of LASIK mono-vision.  Goldberg feels that it was an opportunity of a lifetime to make a substantial contribution to his field:  “It is gratifying to see that LASIK mono-vision is now an accepted option for the surgical correction of presbyopia, and the FDA approval will enable more of our patients to safely enjoy greater freedom from glasses.”

The ABES(American Board of Eye Surgeons) promotes the highest possible quality ophthalmologic surgical care.  The ABES certification programs include a process through which a surgeon’s actual surgical skills and judgment are tested and observed by his or her peers.  The ABES tests surgical skills in cataract/intraocular lens surgery as well as LASIK and corneal transplantation.  In 1989, Dr Goldberg was the first eye surgeon in New Jersey to have surgical skills in cataract and intraocular lens surgery certified by ABES.  In 2002 he became one of 2 New Jersey LASIK surgeons to have surgical skills certified in LASIK by ABES.

The other organization to certify LASIK surgeons is the non-profit, patient advocacy CRSQA(Council of Refractive Surgery Quality Assurance).  According to CRSQA, certification is an important indication of the quality of a LASIK doctor, and once certified, results are re-evaluated every three months.  There are fewer than 250 doctors nationwide who have attained and maintain certification by CRSQA.

Nationwide, there are less than 10 LASIK surgeons with dual certification by ABES and CRSQA.  Daniel B.Goldberg MD of the Atlantic Laser Vision Center in Little Silver, NJ is the only NJ eye surgeon and one of only 10 eye surgeons nationwide to have dual certification in LASIK based on review of actual surgical skills and results.

Information on Dr. Daniel Goldberg and his practice is available at http://www.goldberg4lasik.com/

Laser Vision Correction, including LASIK and related procedures such as PRK(photorefractive keratectomy), and ASA(advanced surface ablation) have become the most common refractive surgical procedures with over 1.4 million procedures yearly in the US.  Steady advances in technology have contributed to the quality of results, and the safety of the procedure.

Consider the added safety of a femtosecond laser flap(e.g. Intralase all-laser LASIK or iLASIK) compared to blade LASIK with a microkeratome.  According to Dr. Goldberg, who is one of the first NJ eye surgeons to pioneer LASIK in New Jersey, and who also was one of the first to bring Intralase all-laser LASIK to the east coast:  “Safety is my top priority.  Using the best technology is part of the process, but proper patient selection and meticulous surgical technique is the key to success.”

The FDA scrutinizes and approves the safety of laser eye surgery technology.  Dr. Goldberg advises patients to seek the best combination of technology and an experienced surgical team.  He feels that surgical certification of actual surgical results is an important protection for patients:  “It demonstrates that the surgeon has the confidence to have their surgical skills and results evaluated.  I have always supported the principle that surgical skills and results should be evaluated objectively.”

Board certification by the American Board of Ophthalmology (ABO) is knowledge based but does not measure surgical skills.  Goldberg says:  “As a result, I continue to voluntarily validate my results thru ABES and CRSQA.  It is part of my service to patients to demonstrate our qualifications, and to protect their vision.”
About Dr. Goldberg

Abour Dr. Daniel Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon.   Dr. Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  Based in Monmouth County, New Jersey, Dr. Goldberg has performed LASIK on patients worldwide and was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.